Compare Oscar Health Inc (OSCR) vs State Street PDR S&P Retail ETF (XRT) Price & Performance

Oscar Health (OSCR) trades at $29.60, up 1.72% with mixed technical signals showing neutral overall momentum. The company reported strong Q1 2026 earnings beat but faces profitability challenges with negative margins. Revenue growth from $11.7B in 2025 to projected $13.3B in 2026 indicates expansion, while cash flow trends show operational improvement. Analyst consensus is divided with 27% buy ratings against a $24.67 price target below current levels.

The stock presents growth potential through revenue expansion and cash flow generation, but profitability concerns and negative ROE pose significant risks. Current valuation at 0.61 P/S suggests reasonable pricing for growth, though execution on margin improvement remains critical for sustained upside.

XRT trades at $88.94, down 0.54% today, with a bullish technical signal from moving averages and neutral oscillators. Support levels are at $87-$88, resistance at $90-$91. The ETF tracks the retail sector, which shows mixed consumer sentiment amid rising energy costs and slowing inflation. Recent retail sales growth has been positive but decelerating, with June up 0.2% after May's 1.0% gain (Census Bureau, June 2026).

Outlook is cautious due to macroeconomic pressures on consumer spending, though the ETF's diversification offers stability. Risks include inflation volatility and weak consumer confidence. Analyst sentiment is mixed, with some downgrades citing headwinds. The technical setup suggests near-term consolidation between support and resistance levels.